BIOMAT Database Logo BIOMAT Database Logo

Interleukin 1 activity in the acquired immunodeficiency syndrome. 1986

C Enk, and J Gerstoft, and S Møller, and L Remvig

Interleukin 1 (IL-1) is a monocyte-derived mediator that participates in the regulation of various T-lymphocyte activities, among them IL-2 production. Since IL-2 deficiency is a central feature in the immunological profile of the acquired immunodeficiency syndrome (AIDS), the production of IL-1 from peripheral blood monocytes from male homosexuals with AIDS was investigated at the same time as the IL-1 responsiveness of monocyte-depleted mononuclear cells (MDC) from the same patients. The IL-1 was produced by lipopolysaccharide-stimulated monocytes and assayed by the capacity of monocyte supernatants to amplify the proliferation of phytohaemagglutinin-stimulated allogeneic MDC from healthy donors as well as murine thymocytes. The IL-1 responsiveness was measured by measuring the enhancing effect of an IL-1 standard on the proliferative response of patients' MDC. The IL-1 production was not reduced compared to the IL-1 production in a control group, but the IL-1 responsiveness of the patients' MDC was depressed. The results indicate that depressed IL-1 production is not one of the immunological disturbances in AIDS, but that the T-lymphocyte accessory properties of IL-1 are affected.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Enk, and J Gerstoft, and S Møller, and L Remvig
Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS).
January 1987, Clinical immunology and immunopathology,
C Enk, and J Gerstoft, and S Møller, and L Remvig
Interleukin-10 and acquired immunodeficiency syndrome lymphomas.
February 1993, Blood,
C Enk, and J Gerstoft, and S Møller, and L Remvig
[Acquired immunodeficiency syndrome (AIDS) (1)].
January 1986, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
C Enk, and J Gerstoft, and S Møller, and L Remvig
Immunopurinogenic enzymatic activity in the acquired immunodeficiency syndrome.
January 1986, Advances in experimental medicine and biology,
C Enk, and J Gerstoft, and S Møller, and L Remvig
Acquired immunodeficiency syndrome. State legislative activity.
November 1987, JAMA,
C Enk, and J Gerstoft, and S Møller, and L Remvig
Use of interleukin-2 in patients with acquired immunodeficiency syndrome.
October 1984, Journal of biological response modifiers,
C Enk, and J Gerstoft, and S Møller, and L Remvig
Acquired Immunodeficiency Syndrome (AIDS) update, Part 1.
January 1999, Hospital topics,
C Enk, and J Gerstoft, and S Møller, and L Remvig
[Acquired ichthyosis in the acquired immunodeficiency syndrome].
June 1984, Presse medicale (Paris, France : 1983),
C Enk, and J Gerstoft, and S Møller, and L Remvig
The acquired immunodeficiency syndrome.
October 1983, Disease-a-month : DM,
C Enk, and J Gerstoft, and S Møller, and L Remvig
The acquired immunodeficiency syndrome.
October 1988, Tropical doctor,
Copied contents to your clipboard!